Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Nathwani

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Drugs|June 14, 2000
Place of parenteral cephalosporins in the ambulatory setting: clinical evidenceD Nathwani
The Journal of Infection|January 19, 1999
Controlling antibiotic use--is there a role for the infectious disease physician?D Nathwani
The Journal of Hospital Infection|April 3, 2002
Economic impact and formulary positioning of linezolid: a new anti-Gram-positive antimicrobialD Nathwani
Lancet (London, England)|February 27, 1993
Malaria and the oil industryD Nathwani
Scottish Medical Journal|December 1, 1993
Vaccination for foreign travel--a growing needD Nathwani
Journal of Chemotherapy (Florence, Italy)|June 21, 2001
Cost and dosing issuesD Nathwani
The Journal of Infection|July 1, 1995
New nucleoside analogues--time for caution?D Nathwani
International Journal of Antimicrobial Agents|December 14, 1999
Cost considerations in the evaluation of new therapies for gram-positive bacteriaD Nathwani, M Malek
QJM : Monthly Journal of the Association of Physicians|January 1, 2000
Antibiotic prescribing--are there lessons for physicians?D Nathwani, P Davey
Scottish Medical Journal|October 1, 1996
Travel medicine--at what cost and who pays?R Fair, D Nathwani
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Drugs|June 14, 2000
Place of parenteral cephalosporins in the ambulatory setting: clinical evidenceD Nathwani
The Journal of Infection|January 19, 1999
Controlling antibiotic use--is there a role for the infectious disease physician?D Nathwani
The Journal of Hospital Infection|April 3, 2002
Economic impact and formulary positioning of linezolid: a new anti-Gram-positive antimicrobialD Nathwani
Lancet (London, England)|February 27, 1993
Malaria and the oil industryD Nathwani
Scottish Medical Journal|December 1, 1993
Vaccination for foreign travel--a growing needD Nathwani
Journal of Chemotherapy (Florence, Italy)|June 21, 2001
Cost and dosing issuesD Nathwani
The Journal of Infection|July 1, 1995
New nucleoside analogues--time for caution?D Nathwani
International Journal of Antimicrobial Agents|December 14, 1999
Cost considerations in the evaluation of new therapies for gram-positive bacteriaD Nathwani, M Malek
QJM : Monthly Journal of the Association of Physicians|January 1, 2000
Antibiotic prescribing--are there lessons for physicians?D Nathwani, P Davey
Scottish Medical Journal|October 1, 1996
Travel medicine--at what cost and who pays?R Fair, D Nathwani
Pageof 17